Sometimes I get lucky with a price forecast, like this one. The story here is that this company is going after the multi-billion dollar injectable drug delivery market with its novel products.
The chart is going to be loose like it has been for awhile longer as the shareholder base broadens and as the story becomes more tangible with earnings and meaningful revenues instead of upfront payments.
However, the chart is very constructive and the news is bullish. Read up on it. This little stock could become a billion dollar company in the next year or two if they keep hitting the way they have been lately.
I'll keep doing my best with the charts, but you look at the fundamentals to confirm what I am saying.
Cheers.
Tim 11:19AM EST, Monday 3/17/2014
Comments
DJCYStocks
⋅
You should also check VNDA as well. It has a non-24 disorder drug Hetlioz that has a significant negative sentiment, but made a strange run up to 19 today, which makes me think that someone wants the price higher so they can unload before the first earnings of the drug in the 2nd Quarter. :)
Listrest
⋅
Hey how is this stock gonna do?
timwest
⋅
Feel free to read the company website - unilife.com I think they are in good position to deliver returns to investors over time. The chart is merely a function of how well they are getting their story out to the general investing public. It is a small cap stock and therefore has plenty of volatility without necessarily any news. I'm constructive on the chart and the company.